REG - MicroSalt PLC - Result of AGM

MicroSaltAnnouncement

21/06/2024 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240621:nRSU4565Ta&default-theme=true

RNS Number : 4565T  MicroSalt PLC  21 June 2024

21 June 2024

MicroSalt Plc

 

("MicroSalt" or the "Company")

 

Result of AGM

 

MicroSalt plc, a company commercialising a patented technology to produce
full-flavour, low-sodium salt for food manufacturers and consumers is pleased
to announce that all resolutions proposed to shareholders at its Annual
General Meeting today were duly passed.

 

The total number of votes received in respect of all resolutions were as
follows:

 

 No.                                                     For                       Against                           Votes Withheld  Total Votes Cast
                                                         Number of Votes  %        Number of Votes  % Votes against
 Ordinary Resolutions
 1. Approval of Annual Report and Accounts               33,958,101       100.00%  0                0.00%            9,086           33,958,101
 2. To re-appointment Crowe U.K. LLP as Auditors         33,935,922       100.00%  0                0.00%            31,265          33,935,922
 3. To authorise Directors to set Auditors remuneration  33,935,922       100.00%  0                0.00%            31,265          33,935,922
 4. To re-elect Rick Guiney as a Director                33,967,187       100.00%  0                0.00%            0               33,967,187
 5. To re-elect Konrad Dabrowski as a Director           33,848,944       99.99%   684              0.002%           117,559         33,849,628
 6. To re-elect Judith Batchelar as a Director           33,849,628       100.00%  0                0.00%            117,559         33,849,628
 7. To re-elect Daniel Emery as a Director               33,817,679       99.99%   684              0.002%           148,824         33,818,363
 8. To re-elect Gary Urmston as a Director               33,818,363       100.00%  0                0.00%            148,824         33,818,363
 9. Authority to Allot Shares                            33,848,944       99.99%   684              0.002%           117,559         33,849,628
 Special Resolution
 10. Disapplication of pre-emption rights                33,818,363       100.00%  0                0.000%           148,824         33,818,363

 

Notes:

1.   Proxy appointments which gave discretion to the Chairman of the AGM
have been included in the "For" total for the appropriate resolution.

2.   Votes "For" and "Against" any resolution are expressed as a percentage
of votes validly cast for that resolution.

3.   A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against".

4.   The number of shares in issue on 21 June 2024 was 47,147,401.

5.   The full text of the resolutions passed at the AGM can be found in the
Notice of Annual General Meeting which is available on the Company's website
at www.microsalt.co.

 

 

For further information, please visit MicroSalt's website
(https://microsaltinc.com/home-uk/) or contact:

 

 MicroSalt plc                                            Via Flagstaff PR
 Rick Guiney, CEO

 Zeus (Nominated Adviser and Broker)                      +44 (0)20 3829 5000
 David Foreman / James Edis (Investment Banking)
 Dom King (Corporate Broking), Rupert Woolfenden (Sales)

 Flagstaff PR (Financial PR/IR)                           +44 (0)20 7129 1474
 Tim Thompson / Alison Allfrey / Anna Probert

 

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its
micron sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average
salt intake was reduced by one gram per day, it has been estimated that 4,147
lives and £288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70 per cent. of the
typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which
helps create high barriers to entry within the reduced-sodium salt market. The
group has a US patent and 14 patent applications pending in other
jurisdictions globally.

 

The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.

 

MicroSalt has a three-pronged marketing strategy, targeting large B2B food
manufacturers, the B2C market and e-commerce customers. MicroSalt's all
natural, low-sodium solution is well positioned to take advantage of the
fast-growing market for a healthier alternative to traditional salt.

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBSGDLLBDDGSB